Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2013/061047external-prioritypatent/WO2014097151A2/en
Application filed by Novartis AgfiledCriticalNovartis Ag
Publication of CU20150065A7publicationCriticalpatent/CU20150065A7/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a nuevos compuestos que son inhibidores de autotaxina, procesos para su preparación, composiciones farmacéuticas y medicamentos que los contienen y a su uso en el tratamiento de una enfermedad o condición dependiente de ATX o mediada por ATX.The present invention relates to new compounds that are autotaxin inhibitors, processes for their preparation, pharmaceutical compositions and medicaments containing them and their use in the treatment of an ATX-dependent or ATX-mediated disease or condition.
CUP2015000065A2013-03-152015-06-19
COMPOUNDS DERIVED FROM BENCIL 4 - ((2- (TRIAZOL-5-IL) ACETAMIDE) METHYL) PIPERIDIN-1- CARBOXYLATE ACTIVE AS AUTOTAXINE INHIBITORS
CU20150065A7
(en)
Compounds derived from substituted spiropyrido [1,2-a] pyrazine, as hiv integrase inhibitors; pharmaceutical composition that includes them; and its use for the prophylaxis or treatment of a hiv infection.
OPTIONALLY CONDENSED HYDERO-CYCLIC DERIVATIVES OF PIRIDIMINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGICAL AND AUTOINMUNITY DISEASES
Compounds derived from thiophene-2-carboxylic acid, flaviviridae virus inhibitors; pharmaceutical composition that includes them; and its use for the treatment of a viral infection by flaviviridae.